Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
DBSPW
Phase 1 Study of Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
1 other identifier
interventional
6
1 country
1
Brief Summary
The purpose of this study is to investigate the safety and efficacy of deep brain stimulation in obese patients with Prader Willi syndrome refractory to conventional treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Oct 2014
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 30, 2014
CompletedFirst Posted
Study publicly available on registry
November 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedDecember 16, 2015
November 1, 2014
2 years
October 30, 2014
December 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
waist circumference; mid-upper arm circumference
6 months
resting energy expenditure
6 months
Body mass index
6 months
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
3 months
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
6 months
Secondary Outcomes (4)
daily food ingestion diary listing
6 months
Child Yale-Brown Obsessive Compulsive Scale
6 months
Child Behaviour Checklist
6 months
Feeding Behaviour Questionnaire
6 months
Study Arms (1)
Deep Brain Stimulation
EXPERIMENTALPatients with Prader-Willi syndrome to receive DBS.
Interventions
Deep Brain Stimulation hypothalamic surgery in patients with Prader-Willi syndrome
Eligibility Criteria
You may qualify if:
- years or older
- Parents able to give informed consent
- Diagnosis of Prader-Willi syndrome confirmed by genetic analysis
- Refractoriness to medical treatment, defined as a weight loss lower than 10% of the body weight with nutritional, pharmacological or surgical interventions
- Severe or morbid obesity
- No contra-indications to the surgical procedure
You may not qualify if:
- Cardiovascular disease that might significantly increase the surgical risk
- Brain lesions detected clinically or during MRI
- Use of cardiac pacemakers/ defibrillators
- Clinical conditions that may require the use of MRI in the post-operative period
- Patients undergoing chemotherapy or immunosuppressive treatments
- Patients unable to return to the hospital at the required intervals
- Previous neurosurgical treatments that may increase the risk of DBS surgery
- Active medical conditions that may require in-hospital treatment in the nearby future
- Previous diagnosis of epilepsy or status epilepticus
- Chronic infection
- Plan to use diathermy
- Metallic implants that might preclude MRI imaging of the brain
- Active participation in other experimental studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HCFUMSP
São Paulo, São Paulo, 0543-010, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Durval Damiani
University of Sao Paulo General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2014
First Posted
November 21, 2014
Study Start
October 1, 2014
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
December 16, 2015
Record last verified: 2014-11